Literature DB >> 27073771

Endoscopic Management of Osgood-Schlatter Disease.

Tun Hing Lui1.   

Abstract

Osgood-Schlatter disease is a common cause of anterior knee pain in sports-practicing adolescents. The long-term outcomes have not always been favorable, and some adolescents have persisting knee pain into adulthood. Excision of the ossicle together with debridement of the tibial tuberosity is indicated if the pain is not relieved with conservative measures. An endoscopic technique for excision of the ossicle associated with Osgood-Schlatter disease is reported. It has the advantages of avoidance of painful surgical scars and preservation of the integrity of the patellar tendon, with the potential for improved cosmetic and functional results.

Entities:  

Year:  2016        PMID: 27073771      PMCID: PMC4811213          DOI: 10.1016/j.eats.2015.10.023

Source DB:  PubMed          Journal:  Arthrosc Tech        ISSN: 2212-6287


  13 in total

1.  Complete resolution of the symptoms of refractory Osgood-Schlatter disease following percutaneous fixation of the tibial tuberosity.

Authors:  Nitisha Narayan; Piers D Mitchell; Mark David Latimer
Journal:  BMJ Case Rep       Date:  2015-02-12

2.  Long-term outcome of Osgood-Schlatter disease: not always favorable.

Authors:  Selami Çakmak; Levent Tekin; Selim Akarsu
Journal:  Rheumatol Int       Date:  2012-12-18       Impact factor: 2.631

3.  Endoscopic Resection of Avulsed Fragment of Tibial Tuberosity and Endoscopic-Assisted Repair of Patellar Tendon.

Authors:  Tun Hing Lui
Journal:  Arthrosc Tech       Date:  2015-12-23

4.  Tibial tuberosity excision for symptomatic Osgood-Schlatter disease.

Authors:  M J Flowers; D R Bhadreshwar
Journal:  J Pediatr Orthop       Date:  1995 May-Jun       Impact factor: 2.324

5.  Direct bursoscopic ossicle resection in young and active patients with unresolved Osgood-Schlatter disease.

Authors:  Sang Soo Eun; Seung Ah Lee; Ramakant Kumar; Eun Jin Sul; Sang Ho Lee; Jin Hwan Ahn; Moon Jong Chang
Journal:  Arthroscopy       Date:  2014-10-24       Impact factor: 4.772

6.  Long-term outcome after surgical treatment of unresolved osgood-schlatter disease in young men: surgical technique.

Authors:  Harri K Pihlajamäki; Tuomo I Visuri
Journal:  J Bone Joint Surg Am       Date:  2010-09       Impact factor: 5.284

7.  Long-term functional and sonographic outcomes in Osgood-Schlatter disease.

Authors:  Derya Ozer Kaya; Ugur Toprak; Gul Baltaci; Baran Yosmaoglu; Hamza Ozer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-07-03       Impact factor: 4.342

8.  Surgical treatment of unresolved Osgood-Schlatter disease: ossicle resection with tibial tubercleplasty.

Authors:  Jennifer M Weiss; Susan S Jordan; Jason S Andersen; B Minsuk Lee; Mininder Kocher
Journal:  J Pediatr Orthop       Date:  2007 Oct-Nov       Impact factor: 2.324

9.  Arthroscopic treatment of unresolved Osgood-Schlatter lesions.

Authors:  Thomas M DeBerardino; Joanna G Branstetter; Brett D Owens
Journal:  Arthroscopy       Date:  2007-03-19       Impact factor: 4.772

10.  Long-term outcome after surgical treatment of unresolved Osgood-Schlatter disease in young men.

Authors:  Harri K Pihlajamäki; Ville M Mattila; Mickael Parviainen; Martti J Kiuru; Tuomo I Visuri
Journal:  J Bone Joint Surg Am       Date:  2009-10       Impact factor: 5.284

View more
  3 in total

1.  Bursoscopic Ultrasound-Guided Ossicle Resection for Osgood-Schlatter Disease.

Authors:  Kentaro Fujita; Junsuke Nakase; Rikuto Yoshimizu; Mitsuhiro Kimura; Tomoyuki Kanayama; Hiroyuki Tsuchiya
Journal:  Arthrosc Tech       Date:  2022-04-22

2.  Hyperosmolar dextrose injection for Osgood-Schlatter disease: a double-blind, randomized controlled trial.

Authors:  Zhe Wu; Xiaoxian Tu; Zhiyuan Tu
Journal:  Arch Orthop Trauma Surg       Date:  2021-10-21       Impact factor: 2.928

3.  Therapeutic interventions in Osgood-Schlatter disease: A case report.

Authors:  Eliza Gaweł; Anna Zwierzchowska
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.